- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Wockhardt Limited — Board Meeting, 10-02-2026: Outcome of Board Meeting
10-02-2026 | 02:32 pm
10-02-2026 | 02:32 pm
Wockhardt's board approved Q3 consolidated results: Revenue ₹888 Cr, Net Profit ₹59 Cr. Key update: the company exited its US generic pharma business, liquidating subsidiaries and recording a ₹97 Cr exceptional charge.
No comments yet. Be the first to comment!